Searchable abstracts of presentations at key conferences in endocrinology

ea0020p184 | Endocrine tumours and neoplasia | ECE2009

Recombinant human thyrotropin in follow-up of patients with differentiated thyroid cancer

Podoba Jan

Background: Despite good prognosis patients with previously treated well-differentiated thyroid cancer (DTC) require lifelong monitoring for recurrent disease. The diagnostic value of radioiodine whole body scanning and serum thyroglobulin (Tg) measurement is most accurate during thyroid stimulating hormone (TSH) stimulation. The introduction of recombinant human TSH (rhTSH)-stimulated testing offers the possibility to avoid hormone withdrawal associated with the morbidity of ...

ea0041gp225 | Thyroid Cancer | ECE2016

Relationship between autoimmune thyroiditis and papillary thyroid cancer

Podoba Jan , Grigerova Marianna , Mojtova Emilia , Griger Martin

Introduction: Coexistence of autoimmune thyroiditis (AIT) and papillary thyroid cancer (PTC) has been well documented, but causality is still a matter of debate. Pathogenetic links between PTC and AIT try to explain two theories: 1) PTC is induced or facilitated by AIT, 2) AIT is a response to PTC. It is believed that PTC associated to AIT has a better prognosis.Aims: To find out: 1) the incidence of AIT in PTC patients, 2) the course of PTC associated t...

ea0037gp.09.01 | Nuclear receptors and signalling | ECE2015

Comparison of mRNA expression pattern of retinoid and retinoid X nuclear receptor subtypes in thyroid carcinomas, breast cancer and renal carcinomas

Brtko Julius , Bialesova Lucia , Lenko Vladimir , Galbavy Stefan , Podoba Jan , Macejova Dana

Introduction: Nuclear retinoid receptors (RARs) upon a ligand binding act as all-trans retinoic acid-inducible transcription factors interacting as heterodimers with nuclear retinoid X (rexinoid) receptors (RXRs). The disruption of retinoic acid (RA) signalling pathways is believed to underlie the etiology of a number of malignancies. Retinoids – cell differentiation agents that may ‘reprogram’ tumours, i.e. retinoic acid derivatives or retinoic acid related com...

ea0020p66 | Thyroid | ECE2009

Differences in expression pattern of all-trans retinoic acid and retinoid X nuclear receptor subtypes in papillary thyroid carcinoma: a comparison with anaplastic thyroid carcinoma

Macejova Dana , Ondkova Slavomira , Galbavy Stefan , Podoba Jan , Kausitz Juraj , Brtko Julius

Retinoid receptors (RARs) upon a proper ligand binding act as all-trans retinoic acid-inducible transcription factors interacting as heterodimers with retinoid X receptors (RXRs). Predominantly, novel synthetic retinoid analogues acting through RARs as redifferentiation agents would be of great value in treating patients with advanced thyroid cancer.The objective of this study was to investigate all-trans retinoic acid/9-cis retinoic acid n...

ea0035p884 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>) | ECE2014

Register of sellar tumors: RESET: diagnostics and therapy of acromegaly in Czech and Slovak Republics

Hana Vaclav , Svancara Jan , Bandurova Lubomira , Brabec Petr , Cap Jan , Durovcova Viktoria , Dvorakova Eva , Hana Vaclav , Jarkovska Zuzana , Kentos Peter , Klimes Daniel , Krcma Michal , Krsek Michal , Lazurova Ivica , Olsovska Vera , Podoba Jan , Pura Mikulas , Sasikova Michaela , Stary Karel , Strenkova Jana , Siprova Helena , Steno Juraj , Trejbalova Ludmila , Vanuga Peter , Wagnerova Hedviga , Weiss Vladimir , Zeman Dalibor , Dusek Ladislav , Marek Josef

Acromegaly is usually diagnosed after several years of duration. The multimodal therapy – surgery, radiotherpy, pharmacotherapy – is necessary in the majority of patients. Register of sellar tumors (RESET) collecting data of patients from eight tertiary centers in the Czech and Slovak Republics since the year 2000 was established in 2008.Aim of analysis: Evaluation of diagnostics of acromegaly and effectiveness of its treatment in a daily pract...